VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,086 | -99.7% | 282,268 | +520.3% | 0.12% | +310.7% |
| Q4 2019 | $747,000 | +20.7% | 45,507 | -2.4% | 0.03% | +7.7% |
| Q3 2019 | $619,000 | -5.9% | 46,623 | -0.2% | 0.03% | 0.0% |
| Q2 2019 | $658,000 | -23.8% | 46,733 | -0.3% | 0.03% | -25.7% |
| Q1 2019 | $863,000 | -64.9% | 46,877 | -53.3% | 0.04% | -31.4% |
| Q4 2018 | $2,461,000 | +113.6% | 100,279 | +99.8% | 0.05% | +15.9% |
| Q3 2018 | $1,152,000 | +20.4% | 50,182 | -0.2% | 0.04% | +12.8% |
| Q2 2018 | $957,000 | +6.1% | 50,260 | -6.1% | 0.04% | +2.6% |
| Q1 2018 | $902,000 | -23.1% | 53,530 | -30.6% | 0.04% | -22.4% |
| Q4 2017 | $1,173,000 | -52.7% | 77,160 | -44.3% | 0.05% | -50.5% |
| Q3 2017 | $2,478,000 | – | 138,446 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |